Neuroderm Ltd.
A maker of wearable drug-delivery systems for Parkinson's disease, this Israeli company developed ND0612, a small pump worn on the body that delivers levodopa continuously under the skin to smooth out the ups and downs of oral medication. Founded in 2003 in Rehovot, Israel, it was acquired by Japan's Mitsubishi Tanabe Pharma in 2017. Its name blends "neuro" (the nervous system) with "derm" (skin), reflecting its signature idea of treating the brain through the skin.
No filing summaries or text available for this security.